A clinical trial for peanut allergy treatment has hit another milestone, with research suggesting graduated doses of peanut protein powder could help protect allergic children.

U-M researchers aim to develop a new immunotherapy that could alter the immune reactions to food. The result: extended relief from peanut allergies.

Recent discoveries about how the immune system reacts to injury — and the dire consequences if that response spirals out of control

The results suggest that graduated doses of peanut protein powder could help protect against the consequences of accidental allergen exposure.

The firestorm of controversy surrounding the epinephrine auto-injector’s rising prices raises additional issues about the U.S. pharma market.